US Patent 9815897 Antibodies directed against programmed death-1 (PD-1)
Patent 9815897 was granted and assigned to AnaptysBio on November, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9815897 Antibodies directed against programmed death-1 (PD-1)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
